Cargando…
Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty: a case report
INTRODUCTION: Rivaroxaban, a new oral anticoagulant, is currently licensed for use in patients undergoing orthopedic surgery. It is more efficacious than other anticoagulants such as low molecular weight heparin and does not require daily monitoring. It has also been shown to be efficacious in patie...
Autores principales: | Boland, Michael, Murphy, Maria, Murphy, Marese, McDermott, Enda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407781/ https://www.ncbi.nlm.nih.gov/pubmed/22584072 http://dx.doi.org/10.1186/1752-1947-6-129 |
Ejemplares similares
-
Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty
Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for
Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018) -
Preoperative planning and postoperative evaluation of total hip arthroplasty that takes combined anteversion
por: Imai, Hiroshi, et al.
Publicado: (2016) -
The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013) -
Discovery of Intra-Abdominal Hemorrhage during Hernioplasty in a Patient Taking Rivaroxaban
por: Chow, Harry, et al.
Publicado: (2015) -
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
por: Levitan, Bennett, et al.
Publicado: (2014)